Notice of Award of a Single-Source Cooperative Agreement To Fund National Center for HIV/AIDS, Dermatology, and STDs, 16017-16018 [2023-05250]

Download as PDF Federal Register / Vol. 88, No. 50 / Wednesday, March 15, 2023 / Notices for BSC, DDID membership each year and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in October 2023, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. Candidates should submit the following items: D Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address). D At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, NIH, FDA). Nominations may be submitted by the candidate or by the person/organization recommending the candidate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–05293 Filed 3–14–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2023–0007] Advisory Committee on Immunization Practices; Amended Notice of Meeting Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). ACTION: Notice of meeting and request for comment. lotter on DSK11XQN23PROD with NOTICES1 AGENCY: The Centers for Disease Control and Prevention (CDC) announces an amendment to the following meeting of the Advisory Committee on Immunization Practices SUMMARY: VerDate Sep<11>2014 18:48 Mar 14, 2023 Jkt 259001 16017 (ACIP). This meeting was open to the public. DEPARTMENT OF HEALTH AND HUMAN SERVICES FOR FURTHER INFORMATION CONTACT: Centers for Disease Control and Prevention Stephanie Thomas, ACIP Committee Management Specialist, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road NE, Mailstop H24–8, Atlanta, Georgia 30329–4027; Telephone: 404–639–8367; Email: ACIP@cdc.gov. Notice is hereby given of a change in the meeting of the Advisory Committee on Immunization Practices (ACIP); February 22, 2023, 8:00 a.m. to 5:15 p.m., EST, February 23, 2023, 8:00 a.m. to 5:00 p.m., EST, and February 24, 2023, 8:00 a.m. to 1:00 p.m., EST (times subject to change, see the ACIP website for updates: https://www.cdc.gov/ vaccines/acip/), in the original Federal Register notice. Notice of the virtual meeting was published in the Federal Register on Monday, January 30, 2023, Volume 88, Number 19, pages 5883–5884. Notice of the virtual meeting is being amended to update the matters to be considered, which should read as follows: Matters To Be Considered: The agenda will include discussions on mpox vaccines, influenza vaccines, pneumococcal vaccine, varicella vaccines, meningococcal vaccines, Polio vaccine, respiratory syncytial virus vaccine pediatric/maternal, respiratory syncytial virus vaccine adult, dengue vaccines, Chikungunya vaccine, and COVID–19 vaccines. A recommendation vote on mpox vaccine is scheduled. For more information on the meeting agenda visit https://www.cdc.gov/vaccines/ acip/meetings/meetings-info.html. Authority: 5 U.S.C. 1001 et. seq. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. SUPPLEMENTARY INFORMATION: Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–05296 Filed 3–14–23; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 Notice of Award of a Single-Source Cooperative Agreement To Fund National Center for HIV/AIDS, Dermatology, and STDs Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services (HHS), announces the award of approximately $1,500,000 for Year 1 funding to the National Center for HIV/ AIDS, Dermatology, and STDS (NCHADS). This award will support implementing a comprehensive combination of HIV prevention, monitoring, diagnosis, and treatment systems; emergency preparedness and response; and reduce the infectious disease burden in Cambodia. Funding amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2023, through September 29, 2028. FOR FURTHER INFORMATION CONTACT: Joyce Neal, Center for Global Health, Centers for Disease Control and Prevention, #80, Samdach Pen Nut Blvd. (289) Sangkat Boeung Kak II, Khan Tuol Kork Phnom Penh, Cambodia, Telephone: 404–433–0184, Email: jxn4@ cdc.gov. SUPPLEMENTARY INFORMATION: The single-source award aims to strengthen the systems and capacity of NCHADS to end HIV as a public health threat and to sustain HIV epidemic control. NCHADS is in a unique position to conduct this work, as it is the only recognized national focal point by the Ministry of Health (MOH) under Sub-decree 67 ANKr.BK. SUMMARY: Summary of the Awards Recipients: National Center for HIV/ AIDS, Dermatology, and STDs (NCHADS). Purpose of the Awards: The purpose of these awards is to support implementing a comprehensive combination of HIV prevention, monitoring, diagnosis, and treatment systems; emergency preparedness and response; and reduce the infectious disease burden in Cambodia. Amount of the Awards: For NCHADS, the approximate year 1 award funding amount is $1,500,000 in Federal Fiscal E:\FR\FM\15MRN1.SGM 15MRN1 16018 Federal Register / Vol. 88, No. 50 / Wednesday, March 15, 2023 / Notices Year (FYY) 2023, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. Authorities: This program is authorized under Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003). Period of Performance: September 30, 2023 through September 29, 2028. Dated: March 9, 2023. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–05250 Filed 3–14–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of Single-Source Cooperative Agreements To Fund Fundac¸a˜o para o Desenvolvimento Cientı´fico e Tecnolo´gico em Sau´de (FIOTEC), Brazil; The Lighthouse Trust, Malawi; and Ghana AIDS Commission (GAC), West Africa Region (Ghana) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), announces the awards of approximately $6,000,000 for Year 1 funding to FIOTEC, Brazil; approximately $13,000,000 for Year 1 to the Lighthouse Trust, Malawi; and approximately $300,000 for Year 1 funding to GAC, Ghana. These awards will support implementation of a comprehensive combination of HIV prevention, monitoring, diagnosis, and treatment systems; emergency preparedness and response; and a reduction of infectious disease burden in Brazil, Malawi, and Ghana. Funding amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2023, through September 29, 2028. FOR FURTHER INFORMATION CONTACT: Brazil: Angel Roca, Center for Global Health, Centers for Disease Control and Prevention, 1600 Clifton Road, MS US1–2 Atlanta, GA 30333, Telephone: (404) 639–6476, Email: axr4@cdc.gov. Malawi: Dr. Dumbani Kayira, Center for Global Health, Centers for Disease Control and Prevention, Malawi Office, lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:48 Mar 14, 2023 Jkt 259001 NICO House, P.O. Box 30016 Lilongwe 3, Malawi, Telephone: +265888969870, Email: kvj2@cdc.gov. West Africa Region (Ghana): Dr. Trong Ao, Center for Global Health, Centers for Disease Control and Prevention, U.S. Embassy, 24 Fourth Circular Rd. Cantonments, Accra, Telephone:: +233302741781, Email: tfa8@cdc.gov. SUPPLEMENTARY INFORMATION: • FIOTEC, Brazil: The single-source award will provide opportunities to support the HIV response consistent with PEPFAR requirements and other public health initiatives that technically support enhancement of public health capacity. FIOTEC is in a unique position to conduct this work, as it is a private, endowed, non-profit foundation with administrative and financial autonomy. And no other national level foundation or non-governmental entity is able to receive and manage funds on behalf of the Brazilian Ministry of Health (MoH) while still meeting USG funding eligibility criteria. • The Lighthouse Trust, Malawi: The single-source award will contribute to sustaining epidemic control through high quality client centered service delivery and national HIV program capacity strengthening. The Lighthouse Trust is in a unique position as the flagship public service provider and technical leader for and within Malawi’s successful national HIV treatment and care program. It is the designated public HIV service provider in the capital city, Lilongwe, and central region’s largest public hospitals, and it is the highest-level referral center for HIV clinical services in the national HIV program, providing clinical oversight and care for complicated patients throughout Malawi. • GAC, West Africa Region (Ghana): The single-source award will support GAC which is the mandated government agency providing leadership and coordination of HIV programs in Ghana through the UNAIDS three ones principle: one agreed HIV/AIDS action framework that provides the basis for coordinating the work of all partners, one national AIDS coordinating authority with a broad-based multisector mandate, and one agreed country level monitoring and evaluation system. GAC holds legal responsibility for formulating policies and designing strategies to respond to Ghana’s HIV and AIDS epidemic, to provide for the management of the fund, to prevent and control the HIV and AIDS epidemic, and to promote and protect the rights of People Living with HIV (PLHIV) and to provide for related purposes. PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 Summary of the Awards Recipients: Fundac ¸a˜o para o Desenvolvimento Cientı´fico e Tecnolo´gico em Sau´de (FIOTEC), Brazil; The Lighthouse Trust, Malawi; Ghana AIDS Commission (GAC), West Africa Region (Ghana). Purpose of the Awards: The purpose of these awards is to support implementing a comprehensive combination of HIV prevention, monitoring, diagnosis, and treatment systems; emergency preparedness and response; and reduce infectious disease burden in Brazil, Malawi, and Ghana. Amount of the Awards: For FIOTEC the approximate year 1 award funding amount is $6,000,000 in Federal Fiscal Year (FYY) 2023, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. For The Lighthouse Trust the approximate year 1 award funding amount is $13,000,000 in Federal Fiscal Year (FYY) 2023, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. For GAC the approximate year 1 award funding amount is $300,000 in Federal Fiscal Year (FYY) 2023, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. Authority: These programs are authorized under Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003). Period of Performance: September 30, 2023 through September 29, 2028. Dated: March 9, 2023. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–05255 Filed 3–14–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Single-Source Cooperative Agreement To Fund the Ministry of Health Zanzibar Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $5,000,000, for Year 1 funding to the Ministry of Health Zanzibar (MOHZ). The award will SUMMARY: E:\FR\FM\15MRN1.SGM 15MRN1

Agencies

[Federal Register Volume 88, Number 50 (Wednesday, March 15, 2023)]
[Notices]
[Pages 16017-16018]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05250]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
National Center for HIV/AIDS, Dermatology, and STDs

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), in the 
Department of Health and Human Services (HHS), announces the award of 
approximately $1,500,000 for Year 1 funding to the National Center for 
HIV/AIDS, Dermatology, and STDS (NCHADS). This award will support 
implementing a comprehensive combination of HIV prevention, monitoring, 
diagnosis, and treatment systems; emergency preparedness and response; 
and reduce the infectious disease burden in Cambodia. Funding amounts 
for years 2-5 will be set at continuation.

DATES: The period for this award will be September 30, 2023, through 
September 29, 2028.

FOR FURTHER INFORMATION CONTACT: Joyce Neal, Center for Global Health, 
Centers for Disease Control and Prevention, #80, Samdach Pen Nut Blvd. 
(289) Sangkat Boeung Kak II, Khan Tuol Kork Phnom Penh, Cambodia, 
Telephone: 404-433-0184, Email: [email protected].

SUPPLEMENTARY INFORMATION: The single-source award aims to strengthen 
the systems and capacity of NCHADS to end HIV as a public health threat 
and to sustain HIV epidemic control. NCHADS is in a unique position to 
conduct this work, as it is the only recognized national focal point by 
the Ministry of Health (MOH) under Sub-decree 67 ANKr.BK.

Summary of the Awards

    Recipients: National Center for HIV/AIDS, Dermatology, and STDs 
(NCHADS).
    Purpose of the Awards: The purpose of these awards is to support 
implementing a comprehensive combination of HIV prevention, monitoring, 
diagnosis, and treatment systems; emergency preparedness and response; 
and reduce the infectious disease burden in Cambodia.
    Amount of the Awards: For NCHADS, the approximate year 1 award 
funding amount is $1,500,000 in Federal Fiscal

[[Page 16018]]

Year (FYY) 2023, subject to the availability of funds. Funding amounts 
for years 2-5 will be set at continuation.
    Authorities: This program is authorized under Public Law 108-25 
(the United States Leadership Against HIV AIDS, Tuberculosis and 
Malaria Act of 2003).
    Period of Performance: September 30, 2023 through September 29, 
2028.

    Dated: March 9, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2023-05250 Filed 3-14-23; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.